Cancer pain Cancer
Conditions
Interventions
An intrathecal catheter is placed at the L4/5 or L3/4 level and the catheter is passed under fluoroscopic guidance to the T10 or T11 vertebral level. Then, a tunneled subcutaneous catheter plus a subc
Sponsors
Chinese association for the study of pain, the minimally invasive interventional group
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Cancer pain
Exclusion criteria
Exclusion criteria: 1. Researchers think that there is any reason can't include 2. IDDS procedure contraindications 3. Uncooperative and unable to finish the self evaluation (PHQ - 9, GAD - 7 and SF-36) 4. Spinal deformity, intolerance to operation 5. The central infection, severe systemic infection 6. The blood coagulation dysfunction; severe liver and kidney dysfunction 7. Patient who has a history of drug abuse
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Pain after treatment, measured using the visual analogue score (VAS) every day during 3 months after treatment 2. Drug cost-effectiveness at 1, 2 and 3 months after treatment | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. The frequency, duration and degree of the flare pain everyday during 3 months after treatment 2. Intensity of anxiety experienced by patient. measured using the PHQ - 9 evaluation scale at 1, 2 and 3months after treatment 3. Intensity of depression experienced by patient, measured by the GAD - 7 anxiety screening scale) at 1, 2 and 3months after treatment 4. Quality of life measured by the quality of life score (SF - 36) at 1, 2 and 3 months after treatment | — |
Countries
China
Outcome results
None listed